KLRA
Kailera Therapeutics, Inc. Common Stock
NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY
$25.15
+0.60% today
Updated 2026-05-01
Market cap
$3.21B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$16 – $28
Volume
1.8M
Kailera Therapeutics, Inc. Common Stock (KLRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |